昌吉早泄治疗的好医院昌吉包皮手术多久可以正常工作,昌吉包皮手术后费用,昌吉医院检测精子质量,昌吉早孕试纸多久能查,昌吉现在大医院做人流多少钱,昌吉性功能障碍的治疗方法,昌吉超导可视无痛人流哪家好

The American Lung Association said on Wednesday that it is advocating to the FDA to take action to reduce what it calls "false" claims that e-cigarettes are a safe alternative to smoking tobacco. The American Lung Association has a campaign known as "Quit. Don't Switch," which encourages smokers to quit altogether rather than switch to vaping. Vaping, the American Lung Association says, should not be considered a safer alternative to smoking tobacco. "One of the biggest problems with e-cigarettes is that many people have switched to e-cigarettes believing it will help them quit tobacco products, which it doesn't," says Albert A Rizzo, M.D., American Lung Association Chief Medical Officer. "Many of them become dual users, meaning they smoke cigarettes when they can and use vaping devices at other times." Rizzo said that e-cigarettes are having a negative effect on reducing smoking rates by introducing young people to smoking who might be attracted to the products due to the flavors. "E-cigarettes have not been found to be safe and effective in helping smokers quit," Dr. Rizzo said. "They were designed to appeal to people who wanted to use something beside a cigarette, or in addition to a cigarette. Instead of helping smokers quit, e-cigarettes have rapidly created another generation addicted to tobacco products by marketing products that appeal to kids, including flavored products like gummy bear, unicorn blood and bubble gum – even apple juice." 1481

The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official.The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced.Public health officials say it will take a year to 18 months to fully validate any potential vaccine. Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea.Even if initial safety tests go well, “you’re talking about a year to a year and a half” before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases.That still would be a record-setting pace. But manufacturers know the wait — required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm — is hard for a frightened public.President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is “moving along very quickly” and he hopes to see a vaccine “relatively soon.”Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the U.S., the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan.For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia. The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover.___The Associated Press receives support for health and science coverage from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 3597

THE BRONX — Police say a man working on a transformer has been killed near an Amtrak rail line in in the Bronx Thursday morning, authorities said.Authorities were called to the scene after 11 a.m.MTA officials said the incident occurred at an Amtrak facility. The facility is located nearby a Con Edison Van Nest substation.FDNY officials confirmed one person was dead and two others sustained minor injuries. They were treated at the scene.The circumstances surrounding the incident were not immediately disclosed.The railroad said on Twitter that trains were being held at Stamford, Connecticut and New York’s Penn Station due to police activity in the Bronx.Video from Citizen App show smoke coming from the scene.This article was written by Kristine Garcia and Cristian Benavides for 800

The Hurricane Center said there is a 100% chance of a tropical depression forming in the Gulf of Mexico. They say by Thursday night it's forecast to become a tropical storm and by Friday it could form into a hurricane.Tropical storm and storm surge watches have been issued for parts of Louisiana.The governor of Louisiana declared a state of emergency on Wednesday ahead of the storm. 397

The House voted Thursday to limit President Donald Trump's ability to take military action against Iran as Democratic criticism of the U.S. killing of a top Iranian general intensified. The resolution does not require the President's signature to be enacted, and Republicans claim the resolution does not have the force of law. Democrats say that under the 1973 War Powers Act, it would be binding if also approved by the Senate. The matter has not been definitively decided by federal courts. A similar proposal by Sen. Tim Kaine, D-Va., faces an uphill fight in the GOP-run Senate.Speaker Nancy Pelosi, D-Calif., said during her weekly press conference that the strike that killed Gen. Qassem Soleimani was "provocative and disproportionate." The House vote came after two U.S. officials, speaking on the condition of anonymity, told reporters that it is "highly likely" that Iran is 898